[HTML][HTML] Molecular pathogenesis, immunopathogenesis and novel therapeutic strategy against COVID-19

SK Chatterjee, S Saha, MNM Munoz - Frontiers in molecular …, 2020 - frontiersin.org
… ” is considered as an attractive alternative approach in analyzing suitable drug … novel
COVID-19. Moreover, our review mainly focuses on the most state-of-the-art therapeutic approach

[HTML][HTML] Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy

Y Shimizu - World Journal of Clinical Cases, 2020 - ncbi.nlm.nih.gov
… In conclusion, the treatment strategy for patients with COVID-19 should be carefully designed
based on both viral kinetics and immunopathogenesis. However, pandemic infection with …

COVID-19: immunopathogenesis and Immunotherapeutics

L Yang, S Liu, J Liu, Z Zhang, X Wan… - … and targeted therapy, 2020 - nature.com
… in patients with COVID-19 must be elucidated to guide clinical … In this review, we discuss
the immunopathology of COVID-19, its … of new therapeutic strategies against COVID-19. …

Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn

M Shahgolzari, A Yavari, Y Arjeini, SM Miri, A Darabi… - Gene reports, 2021 - Elsevier
… responses and immunopathogenesis of COVID-19, suggesting … Therapy strategies such as
inhibition of SARS-CoV-2 fusion/… strategies are racing to develop a treatment against COVID-…

[HTML][HTML] Immunopathogenesis and treatment of cytokine storm in COVID-19

JS Kim, JY Lee, JW Yang, KH Lee, M Effenberger… - Theranostics, 2021 - ncbi.nlm.nih.gov
… in the pathogenesis of cytokine storm, and thus selectively inhibiting dysregulated macrophages
using liposomes or synthetic nanoparticles can be a novel therapeutic approach for the …

[HTML][HTML] Recent insight into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19

S Lega, S Naviglio, S Volpi, A Tommasini - Vaccines, 2020 - mdpi.com
… To date a possible therapeutic approach could involve an antiviral and a cell-entry inhibitor
for the first phase and an immunomodulant such as a IL6 or IL1 blocker for the second phase …

Immune immunomodulation in coronavirus disease 2019 (COVID-19): strategic considerations for personalized therapeutic intervention

MW Hall, I Joshi, L Leal, EE Ooi - Clinical Infectious Diseases, 2022 - academic.oup.com
… the pathogenesis of coronavirus disease 2019 (COVID-19) … immune responses in patients
with COVID-19. Despite the still … of therapeutic strategies for those affected with severe COVID-…

Cytokine storm in COVID-19: immunopathogenesis and therapy

C Zanza, T Romenskaya, AC Manetti, F Franceschi… - Medicina, 2022 - mdpi.com
… met, and other therapeutic strategies are being tested in the … a crucial role in the pathogenesis
of COVID-19, researchers … (CRS) secondary to CAR-T cell therapy and HLH [62,63,64]. …

COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons

SH Nile, A Nile, J Qiu, L Li, X Jia, G Kai - Cytokine & growth factor reviews, 2020 - Elsevier
… However, it is difficult to imagine how the direct antiviral properties of Remdesivir could be
potently active during the immunopathogenic ARDS phase of COVID-19 disease, suggesting …

Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19

M Motallebnezhad, M Omraninava, HEG Ghaleh… - … -Research and Practice, 2023 - Elsevier
… molecular mechanisms underlying the pathogenesis of SARS-… therapeutic approach to the
management of COVID-19. Recently, extracellular vesicle (EV)-based therapeutic strategies